Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarvjeet Das

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochemical and Biophysical Research Communications|June 7, 2026
Integrated bioinformatics and ex-vivo evaluation of resveratrol in modulating oxidative stress and neutrophil extracellular traps in COPDAnshu Kumar, Sarvjeet Das, Nabin Koirala, et al.
International Immunopharmacology|May 5, 2026
Targeting iNOS and associated proteins in neutrophils: An in-silico and ex-vivo approach for anti-sepsis therapySarvjeet Das, Anshu Kumar, Gaurang Agarwal, et al.
Biochemical and Biophysical Research Communications|February 10, 2026
Unveiling the therapeutic potential of Resveratrol against neutrophil-mediated hyperinflammation in sepsis: An in-silico, molecular docking, and ex-vivo approachGaurang Agarwal, Sarvjeet Das, Anshu Kumar, et al.
Future Microbiology|February 19, 2026
Repurposing statins as potential antifungal agents for <i>Candida albicans</i>: <i>in-vitro</i> and <i>in-silico</i> approachMegha Patel, Charmi Patil, Bornika Kalapahad, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 27, 2024
Biomarkers in sepsisJuhi Saxena, Sarvjeet Das, Anshu Kumar, et al.
Current Pharmaceutical Design|December 18, 2024
Immunopharmacological Insights into <i>Cordyceps</i> spp.: Harnessing Therapeutic Potential for SepsisJuhi Saxena, Gaurang Agarwal, Sarvjeet Das, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochemical and Biophysical Research Communications|June 7, 2026
Integrated bioinformatics and ex-vivo evaluation of resveratrol in modulating oxidative stress and neutrophil extracellular traps in COPDAnshu Kumar, Sarvjeet Das, Nabin Koirala, et al.
International Immunopharmacology|May 5, 2026
Targeting iNOS and associated proteins in neutrophils: An in-silico and ex-vivo approach for anti-sepsis therapySarvjeet Das, Anshu Kumar, Gaurang Agarwal, et al.
Biochemical and Biophysical Research Communications|February 10, 2026
Unveiling the therapeutic potential of Resveratrol against neutrophil-mediated hyperinflammation in sepsis: An in-silico, molecular docking, and ex-vivo approachGaurang Agarwal, Sarvjeet Das, Anshu Kumar, et al.
Future Microbiology|February 19, 2026
Repurposing statins as potential antifungal agents for <i>Candida albicans</i>: <i>in-vitro</i> and <i>in-silico</i> approachMegha Patel, Charmi Patil, Bornika Kalapahad, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|July 27, 2024
Biomarkers in sepsisJuhi Saxena, Sarvjeet Das, Anshu Kumar, et al.
Current Pharmaceutical Design|December 18, 2024
Immunopharmacological Insights into <i>Cordyceps</i> spp.: Harnessing Therapeutic Potential for SepsisJuhi Saxena, Gaurang Agarwal, Sarvjeet Das, et al.
Pageof 1